Why is Novartis India falling/rising?

As of 10-Jul, Novartis India Ltd is experiencing a price increase, currently at 1,072.00, reflecting a rise of 29.9 or 2.87%. The stock has shown strong performance today, outperforming its sector by 3.44% and reaching an intraday high of Rs 1,081.95, which is a 3.82% increase. Additionally, Novartis India is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The stock has also seen a significant increase in delivery volume, rising by 118.53% against the 5-day average, which suggests heightened investor interest. Furthermore, the company has demonstrated healthy long-term growth, with operating profit increasing at an annual rate of 141.64%, and recent positive financial results have contributed to the stock's upward movement.
In the broader market context, Novartis India has outperformed the benchmark Sensex over the past week, with a return of +1.98% compared to the Sensex's -0.06%. Over the past month, the stock has also shown a solid return of +5.11% against the Sensex's +0.97%. Despite a decline of 7.59% over the past year, the stock's year-to-date performance of +16.55% significantly exceeds the Sensex's +6.46%, indicating a strong recovery and investor confidence in the company's future prospects.